SBP Group Eyes Innovation as It Shifts Beyond Generics
Source:
bloombergMarkets
June 22, 2026 · 20:44
SBP Group CEO Eric Tse discusses his outlook for China's healthcare sector and how one of China's old-guard pharmaceutical players aims to transition from generics focused model to drug development. He speaks with Stephen Engle from the sidelines of 'The World Economic Forum's Annual Meeting of the New Champions' in Dalian. (Source: Bloomberg)
The original article opens on the publisher's website.
More from Economy
View topic →China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says
cnbc
Sep 1, 2026 · 16:52
US diesel prices soar as Trump hauls in refiners
financialTimes
Sep 1, 2026 · 14:18
Anthropic's Claude Fable 5.1 and Mythos 5.1 arrive with a 75% cost reduction for Fable cache reads
ventureBeat
Sep 1, 2026 · 11:41
Prediction market traders think job creation rebounded in August
cnbc
Sep 1, 2026 · 11:16
Your files stay put: Perplexity’s hybrid AI keeps confidential data off the cloud
ventureBeat
Sep 1, 2026 · 08:00
Countries mentioned